Side Effects of Ozempic (Semaglutide)
Ozempic commonly causes gastrointestinal side effects—particularly nausea, vomiting, diarrhea, constipation, and abdominal pain—which are typically dose-dependent and most pronounced during initial treatment or dose escalation. 1, 2
Most Common Side Effects
Gastrointestinal Effects (Most Frequent)
- Nausea, vomiting, diarrhea, abdominal pain, and constipation are the most common adverse effects, occurring in ≥5% of patients treated with Ozempic 2
- These gastrointestinal symptoms are dose-dependent and typically more severe during initial treatment or when increasing doses 1, 3
- Gradual dose titration is recommended to minimize these gastrointestinal side effects 1, 3
- Most gastrointestinal effects are transient and mild-to-moderate in severity, subsiding with time 4
Practical Management of GI Side Effects
- To manage nausea and vomiting, reduce meal size 1
- To reduce reflux symptoms, limit alcohol and carbonated drinks 1
- Avoid high-fat diets to help with constipation 1
Serious Adverse Events
Overall Risk Profile
- Clinical trials demonstrate a 38% higher risk of serious adverse events with semaglutide compared to placebo 1, 3
Specific Serious Complications
Pancreatitis:
- Increased risk of inflammation of the pancreas 1, 3
- Stop using Ozempic immediately and seek medical attention if you develop severe abdominal pain that will not go away, with or without vomiting 2
- The pain may radiate from abdomen to back 2
Gallbladder Disease:
- Increased risk of cholelithiasis (gallstones) and cholecystitis 1, 3
- Regular monitoring for gallbladder disease is advised 1
Kidney Problems:
- Risk of acute kidney injury, particularly in patients with pre-existing kidney disease 3
- Diarrhea, nausea, and vomiting may cause dehydration, which can worsen kidney problems 2
- It is important to drink fluids to help reduce your chance of dehydration 2
- Regular monitoring of renal function is advised, especially in those experiencing severe gastrointestinal side effects 1
Cardiovascular Events:
- Acute myocardial infarction has been reported in clinical trials 1, 3
- However, semaglutide has also been shown to reduce cardiovascular death, heart attack, and stroke in adults with obesity or overweight and cardiovascular disease (major cardiovascular events occurred in 6.5% with semaglutide vs. 8% with placebo) 1
Vision Changes:
- Risk of diabetic retinopathy complications 1
- Tell your healthcare provider if you have changes in vision during treatment with Ozempic 2
Hypoglycemia Risk
- Your risk for low blood sugar is higher if you use Ozempic with another medicine that can cause low blood sugar, such as sulfonylureas or insulin 1, 2
- Signs and symptoms include: dizziness, blurred vision, anxiety, sweating, slurred speech, hunger, confusion, shakiness, weakness, headache, fast heartbeat, and feeling jittery 2
Other Notable Side Effects
- Injection site reactions 1
- Insomnia has been documented as a side effect 3
- Risk of suicidal ideation has been reported 1
- Cardiac arrhythmia/tachycardia may occur; if symptomatic, monitoring and consideration of beta blockers may be necessary 1
- Delayed gastric emptying, which may affect absorption of other medications 3
- Severe allergic reactions: Stop using Ozempic and get medical help immediately if you develop itching, rash, or difficulty breathing 2
Absolute Contraindications
Thyroid Cancer Risk:
- Ozempic carries an FDA Black Box Warning regarding the risk of thyroid C-cell tumors based on rodent studies 1
- Contraindicated in patients with personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 1, 3
Pregnancy and Breastfeeding:
- Pregnancy or breastfeeding is an absolute contraindication for semaglutide use 1
Special Populations Requiring Caution
Gastroparesis:
- Patients with severe gastroparesis may experience worsened symptoms due to delayed gastric emptying 1
- Not recommended in patients with clinically meaningful gastroparesis 1
Prior Gastric Surgery:
- Careful consideration required for patients with prior gastric surgery, including bariatric surgery 1
Renal Impairment:
- Can be used with caution in severe renal impairment or end-stage renal disease, unlike some other GLP-1 receptor agonists 1
- Patients with severe renal impairment require careful monitoring due to increased risk of gastrointestinal side effects and potential dehydration 1
Oral Contraceptives:
- For patients using oral hormonal contraceptives, consider switching to a non-oral contraceptive method or adding a barrier method for 4 weeks after initiation and after each dose escalation due to potential reduced efficacy from delayed gastric emptying 1
Monitoring Recommendations
- Regular monitoring of renal function, especially during severe gastrointestinal symptoms 1
- Monitor for signs of pancreatitis 1
- Monitor for gallbladder disease 1
- Check blood sugar as directed by your healthcare provider 2
- Regular blood tests including blood sugar levels and hemoglobin A1C 2
- Monitor sleep disturbances, especially during initial titration phase 3
Common Pitfalls to Avoid
- Do not mix insulin and Ozempic together in the same injection 2
- Do not share your Ozempic pen with other people, even if the needle has been changed, as this may transmit serious infections 2
- Discontinuation due to gastrointestinal events occurs in approximately 4.5% of patients 4
- If more than 5 days have passed since a missed dose, skip it and take your next dose on the regularly scheduled day 2